Cystic fibrosis Clinical Trials
Recruiting cystic fibrosis studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat cystic fibrosis. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting cystic fibrosis studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting cystic fibrosis trials
Novel Point-of-care Sweat Chloride Testing Device for Monitoring CFTR Function
Effects of High-Frequency Chest Wall Oscillation Combined With Concurrent Training on Cough,in Cystic Fibrosis Patients
Tele-Rehabilitation in Adults With Cystic Fibrosis
Safety and Efficacy of Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients Aged ≥12 Years
Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants
Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants
Study of the Prevalence of Active/Passive Smoking and Vaping Among Patients With Cystic Fibrosis
A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine
Comparative Effects of Mechanical and Manual Airway Clearance Techniques in Cystic Fibrosis
Assessing Tenapanor as a Treatment of CF-related Constipation.
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
Oral Health Status of Cystic Fibrosis Patients. An Online Survey in Collaboration With the Vaincre la Mucoviscidose Patient Association.
Maralixibat in Patients With Cystic Fibrosis and Constipation
Remote Sputum Collection in Cystic Fibrosis
Continuous Glucose Monitoring and OGTT Screen for Cystic Fibrosis Related Diabetes in Cystic Fibrosis
Evaluation of New Device for Beta-adrenergic Sweat Test in the Context of Stratification of Patient With Cystic Fibrosis
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
Impact of a Coordinated Dietetic-adapted Physical Activity Program on the Percentage of Lean Body Mass in Adults With Cystic Fibrosis Treated With Elexacaftor-Tezacaftor-Ivacaftor: Multicentre Randomised Controlled Trial
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Physical Activity Profile and Sedentary Behaviour in Adults With Cystic Fibrosis
A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
Establishment of a Primary Epididymal Cell Model From Epididymal Samples to Study CFTR Gene Regulation
Acoustic Waveform Respiratory Evaluation
Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic Fibrosis (CF)
A Usability Validation of the MuCopilot Mobile Application, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
Circadian Rhythm Disorders in Children With Cystic Fibrosis Under CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) Modulators
Skeletal Health and Bone Marrow Composition in Adolescents With Cystic Fibrosis
CFTR Modulators in Pregnancy and Postpartum
Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria
A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF
Regional Monitoring of CF Lung Disease
Impact of Highly Effective Modulator Therapy on the Cystic Fibrosis Microbiome
ENHANCE- Establishing Natural History in an Advanced New CF Care Era
Lung Transplant READY CF 2: CARING CF Ancillary RCT
The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes
Peer-supporting for Teenagers With Cystic Fibrosis in the Transition of Care From Paediatric to Adult Services
CF Organization of Care in the Era of Highly Effective Modulator.
Evaluation of Long-Term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor in Cystic Fibrosis Participants 1 Year of Age and Older
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
FEED-Cystic Fibrosis (FEED-CF)
Estrogen Supplementation and Bone Health in Women With CF
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Sinus Disease in Young Children With Cystic Fibrosis
Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis
Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People with Cystic Fibrosis
Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases
Prospective Healthcare-Associated Links in Transmission of Nontuberculous Mycobacteria
COVID-19 Antibody Responses In Cystic Fibrosis
BEGIN Novel ImagiNG Biomarkers
Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine
Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
Identification of Dysglycemia With Continuous Glucose Monitoring to Assess Clinical Evolution in Cystic Fibrosis
Cystic fibrosis clinical trials — common questions
Are cystic fibrosis clinical trials free to join?
Yes. Participating in a cystic fibrosis clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a cystic fibrosis clinical trial?
Each cystic fibrosis study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a cystic fibrosis trial near me?
Use the location controls above. We'll show recruiting cystic fibrosis trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many cystic fibrosis trials are recruiting right now?
We're currently tracking roughly 61 recruiting cystic fibrosis trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.